Features of schizophrenia following premorbid eating disorders.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
08 2019
Historique:
received: 07 03 2019
revised: 20 06 2019
accepted: 20 06 2019
pubmed: 30 6 2019
medline: 1 4 2020
entrez: 30 6 2019
Statut: ppublish

Résumé

Eating disorders (ED) and schizophrenia are frequently comorbid and schizophrenia shares genetic susceptibility with anorexia. Many factors associated with schizophrenia can disrupt eating, but ED can present years before schizophrenia. If premorbid ED distinguishes a particular subtype of schizophrenia, then phenotypic features may differ between schizophrenia cases with and without premorbid ED. This secondary analysis used data from an inpatient schizophrenia research study that comprehensively assessed life course psychiatric disorders (DIGS interview), intelligence (WAIS), global assessments of function (GAF) and assessed symptoms during medication-free and fixed dose neuroleptic phases (PANSS). Premorbid ED was identified in 27 of the 288 schizophrenia cases (9.4%). This group had more females than the group without premorbid ED (74.1% vs. 30%); premorbid ED was 5-fold more common in female than male cases (χ Premorbid ED may define a specific subtype of schizophrenia that is common in females. Their more severe psychotic symptoms and better IQ, despite similarly impaired function and negative symptoms as other cases, suggests a distinct pathophysiology. Premorbid ED should be considered in evaluating risk states for schizophrenia, and as a relevant phenotype for treatment resistant schizophrenia.

Identifiants

pubmed: 31254876
pii: S0165-1781(19)30533-5
doi: 10.1016/j.psychres.2019.06.035
pii:
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-280

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Dolores Malaspina (D)

Ichan Medical School at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA. Electronic address: dolores.malaspina@mssm.edu.

Julie Walsh-Messinger (J)

Department of Psychology, University of Dayton, Dayton, OH, USA; Department of Psychiatry, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.

Anna Brunner (A)

Ichan Medical School at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA.

Nadia Rahman (N)

Ichan Medical School at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA.

Cheryl Corcoran (C)

Ichan Medical School at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA.

David Kimhy (D)

Ichan Medical School at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA.

Raymond R Goetz (RR)

Ichan Medical School at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA.

Sarah Bellovin Goldman (SB)

Counseling and Psychiatric Service, Georgetown University, Washington DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH